CVEs / CVE-2021-24175
CVE-2021-24175: Unknown The Plus Addons for Elementor Page Builder vulnerability
- critical 9.8 CVSS 3.1 (NVD)
- EPSS 16.5% chance of exploitation in the next 30 days, higher than 97% of CVEs (3 Nov 2026)
- Last changed at its sources
Are you affected? Check your servers with Stackurity: it lists the software on each server and the vulnerabilities to fix first.
Check your servers with Stackurity Already using Stackurity? Search for CVE-2021-24175
Description
The Plus Addons for Elementor Page Builder WordPress plugin before 4.1.7 was being actively exploited to by malicious actors to bypass authentication, allowing unauthenticated users to log in as any user (including admin) by just providing the related username, as well as create accounts with arbitrary roles, such as admin. These issues can be exploited even if registration is disabled, and the Login widget is not active.
Affected and fixed versions
| Product | Affected | Fixed in |
|---|---|---|
| Unknown The Plus Addons for Elementor Page Builder | from 4.1.7, before 4.1.7 | 4.1.7 |
Exploitation
Not in the CISA Known Exploited Vulnerabilities catalog as of 3 Nov 2026.
Severity
| CVSS 3.1 | 9.8 criticalCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HScored by NVD |
|---|---|
| Weakness | CWE-287 |
References
- CVE-2021-24175 on NVD
- https://posimyth.ticksy.com/ticket/2713734/ Broken Link
- https://wpscan.com/vulnerability/c311feef-7041-4c21-9525-132b9bd32f89 Exploit, Third Party Advisory
- https://www.wordfence.com/blog/2021/03/critical-0-day-in-the-plus-addons-for-elementor-allows-site-takeover/ Third Party Advisory
Sources
Exploitation status from the CISA Known Exploited Vulnerabilities catalog. EPSS scores from FIRST. Descriptions, severity and references from the National Vulnerability Database. Open-source package versions from OSV (CC-BY 4.0). Text is shown as each source states it; Stackurity does not edit it. Check the vendor's advisory before acting.
This product uses data from the NVD API but is not endorsed or certified by the NVD.